New reimbursement codes in Belgian Nomenclature to come into effect from June 1st of 2017

16

May 2017

The Nomenclature of health benefits includes the benefits (with specific hospital and ambulatory codes) reimbursed by health care insurance, partially or totally. The Nomenclature and changes are published in the Belgian Official Gazette.

Changes will be made in nine chapters of Nomenclature. In relation to medical technologies and in-vitro diagnostics, the most important changes include changes in conditions for two ophthalmology and endoscopy codes, new conditions for reimbursement of photodynamic therapy in dermatology, introduction of two new codes for IVDs, and creating of requirements for reimbursement of number of IVD tests in pregnancy.

The changes of the following articles of the Nomenclature will come into force since June 1, 2017:

Key changes in the "Ophthalmology" section

The following procedures cannot be certified as refractive surgery:

  • Extraction of the crystalline lens (regardless the technique), including the possible intraocular implantation of a lens (246595-246606)
  • Extracapsular extraction of the lens by fragmentation by ultrasound, laser or other similar method, including the possible implantation of a lens (246912-246923)

Key changes in the "Internal Medicine" section

Conditions of reimbursement for the following procedures have been updated:

  • Examination of the upper digestive tract by endoscopy (473056-473060): the procedure should be reimbursed not more than once every 3 years unless the justification for a shorter period is included in the examination report
  • Excision of colon, ileum or jejunum polyp (s), with a diathermic loop, by endoscopy (473211-473222 and 473955-473966): the procedure cannot be performed on rectosigmoid polyps ≤ 5 mm

Key changes in the "Dermatovenereology" chapter

New conditions of reimbursement for Dynamic phototherapy (532770-532781) have been implemented:

  • The procedure is performed for the treatment of neoplastic or pre-neoplastic lesions of the skin and mucous membranes
  • The procedure requires the application of a photosensitizer and artificial light
  • The procedure is reimbursed up to 3 times per day
  • The procedure is reimbursed only once for the treatment of lesions located in the same field of illumination
  • For treatment of lesions in different illumination fields, the reimbursement of second and third procedures is reduced by 50%
  • The service cannot be delivered together with:
    • a dermabrasion procedure (532593-532604, 532210-532221)
    • a procedure for the removal or destruction of mucocutaneous lesion (353231-353242, 532630-532641)

Key changes in the "Clinical biology" chapter

New codes for the following IVD-tests have been implemented:

  • specific IgM antibodies against Cytomegalovirus during pregnancy (552274-552285 and 552296-552300
  • specific IgG antibodies against Toxoplasma Gondii during pregnancy (552392-552403 and 552414-552425)

Specific conditions of reimbursement during pregnancy have been implemented for the following IVD-tests:

  • specific IgM antibodies against Cytomegalovirus during pregnancy (552274-552285 and 552296-552300): can only be provided if there is a clinical presumption of acute Cytomegalovirus infection during pregnancy
  • specific IgG antibodies against Toxoplasma Gondii during pregnancy (552392-552403 and 552414-552425): can be performed only twice during pregnancy
  • specific IgM antibodies against cytomegalovirus (551316-551320 and 551331-551342): procedure code cannot be used during pregnancy
  • IgG antibodies against Toxoplasma Gondii (551751-551762): procedure code cannot be used during pregnancy with the exception of a clinical presumption of an acute Toxoplasma Gondii infection
  • specific IgM antibodies against Toxoplasma Gondii (551773-551784): procedure code cannot be used during pregnancy with the exception of a clinical presumption of an acute Toxoplasma Gondii infection

Subscribe to our biweekly newsletter not to miss important reimbursement information.

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

15

Mar 2022

The Belgian Health Care Knowledge Center (KCE) initiated a study aimed at defining a clear and transparent procedure for the evaluation of digital health technologies in Belgium.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more